Literature DB >> 16927099

Potential effect on cellular response to cadmium of a single-nucleotide A --> G polymorphism in the promoter of the human gene for metallothionein IIA.

Kayoko Kita1, Nobuhiko Miura, Minoru Yoshida, Kentaro Yamazaki, Takayoshi Ohkubo, Yutaka Imai, Akira Naganuma.   

Abstract

Most people generally ingest cadmium in their food. Cadmium that has accumulated in tissues induces the synthesis of metallothioneins (MTs) which are metal-binding proteins that bind tightly to cadmium to inhibit its renal toxicity. Individuals whose ability to induce the synthesis of MTs is low seem likely to be particularly susceptible to the toxic effects of cadmium. In this study, we analyzed the polymorphism of the promoter region of the gene for MT-IIA, the major species of MT in humans, in 119 adult Japanese subjects. We found that about 18% of the subjects had an A --> G single-nucleotide polymorphism in the core region of the promoter near the TATA box. A reporter-gene assay using HEK293 cells showed that replacement of A by G at position -5 reduced the efficiency of the cadmium-induced transcription of the gene for MT-IIA. This single-nucleotide polymorphism inhibited the binding of nuclear proteins to the core promoter region of the gene for MT-IIA. When the promoter region upstream of the TATA box was replaced by a sequence that contained three dioxin-responsive elements, the reporter-gene assay demonstrated that the A --> G single-nucleotide polymorphism resulted in a marked reduction in the rate of dioxin-induced transcription. These results suggest that the A --> G single-nucleotide polymorphism reduces the efficiency of those aspects of the transcription of the gene for MT-IIA that are controlled by general transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927099     DOI: 10.1007/s00439-006-0238-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  27 in total

1.  Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice.

Authors:  Y Okazaki; N Miura; M Satoh; N Imura; A Naganuma
Journal:  Biochem Biophys Res Commun       Date:  1998-04-28       Impact factor: 3.575

2.  Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells.

Authors:  M M Müller; E Schreiber; W Schaffner; P Matthias
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  Protection of carbon tetrachloride-induced hepatotoxicity by zinc: role of metallothionein.

Authors:  S Z Cagen; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1979-10       Impact factor: 4.219

4.  Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene.

Authors:  S Koizumi; K Suzuki; Y Ogra; H Yamada; F Otsuka
Journal:  Eur J Biochem       Date:  1999-02

5.  Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.

Authors:  Y Liu; J Liu; S M Habeebu; M P Waalkes; C D Klaassen
Journal:  Toxicol Sci       Date:  2000-09       Impact factor: 4.849

6.  Age-dependent changes in metallothionein levels in liver and kidney of the Japanese.

Authors:  M Yoshida; H Ohta; Y Yamauchi; Y Seki; M Sagi; K Yamazaki; Y Sumi
Journal:  Biol Trace Elem Res       Date:  1998-08       Impact factor: 3.738

7.  Cadmium-induced proximal tubular dysfunction in a cadmium-polluted area.

Authors:  H Saito; R Shioji; Y Hurukawa; K Nagai; T Arikawa
Journal:  Contrib Nephrol       Date:  1977       Impact factor: 1.580

8.  Purification and characterization of a protein that binds to metal responsive elements of the human metallothionein IIA gene.

Authors:  F Otsuka; A Iwamatsu; K Suzuki; M Ohsawa; D H Hamer; S Koizumi
Journal:  J Biol Chem       Date:  1994-09-23       Impact factor: 5.157

9.  Localization of subunits of transcription factors IIE and IIF immediately upstream of the transcriptional initiation site of the adenovirus major late promoter.

Authors:  F Robert; D Forget; J Li; J Greenblatt; B Coulombe
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

10.  Cadmium in blood and urine--impact of sex, age, dietary intake, iron status, and former smoking--association of renal effects.

Authors:  Ing-Marie Olsson; Inger Bensryd; Thomas Lundh; Helena Ottosson; Staffan Skerfving; Agneta Oskarsson
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

View more
  14 in total

1.  Differential gene-expression of metallothionein 1M and 1G in response to zinc in sertoli TM4 cells.

Authors:  Fatemeh Kheradmand; Issa Nourmohammadi; Mohammad Hossein Modarressi; Mohsen Firoozrai; Mohammad Amin Ahmadi-Faghih
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

2.  The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?

Authors:  Deniz Tekin; Zeliha Kayaaltı; Tülin Söylemezoğlu
Journal:  Int Arch Occup Environ Health       Date:  2011-10-18       Impact factor: 3.015

3.  The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population.

Authors:  Zeliha Kayaalti; Tülin Söylemezoğlu
Journal:  Mol Biol Rep       Date:  2009-07-02       Impact factor: 2.316

4.  Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.

Authors:  Katarzyna Starska; Anna Krześlak; Ewa Forma; Jurek Olszewski; Iwona Lewy-Trenda; Ewa Osuch-Wójcikiewicz; Magdalena Bryś
Journal:  Med Oncol       Date:  2014-06-22       Impact factor: 3.064

5.  Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.

Authors:  Scott V Adams; Brian Barrick; Emily P Christopher; Martin M Shafer; Karen W Makar; Xiaoling Song; Johanna W Lampe; Hugo Vilchis; April Ulery; Polly A Newcomb
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-31       Impact factor: 4.219

6.  Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.

Authors:  Anna Krześlak; Ewa Forma; Paweł Jóźwiak; Agnieszka Szymczyk; Beata Smolarz; Hanna Romanowicz-Makowska; Waldemar Różański; Magdalena Bryś
Journal:  Clin Exp Med       Date:  2012-10-06       Impact factor: 3.984

7.  Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma).

Authors:  Katarzyna Starska; Magdalena Bryś; Ewa Forma; Jurek Olszewski; Piotr Pietkiewicz; Iwona Lewy-Trenda; Olga Stasikowska-Kanicka; Marian Danilewicz; Anna Krześlak
Journal:  Tumour Biol       Date:  2015-06-03

8.  Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China.

Authors:  Jie Liu; Min-Liang Cheng; Qin Yang; Ke-Ren Shan; Jun Shen; Yushu Zhou; Xinjiang Zhang; Anna L Dill; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2007-07       Impact factor: 9.031

Review 9.  The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective.

Authors:  Tomoki Kimura; Taiho Kambe
Journal:  Int J Mol Sci       Date:  2016-03-04       Impact factor: 5.923

10.  Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.

Authors:  Yuta Hattori; Mariko Naito; Masahiko Satoh; Masahiro Nakatochi; Hisao Naito; Masashi Kato; Sahoko Takagi; Takashi Matsunaga; Toshio Seiki; Tae Sasakabe; Shino Suma; Sayo Kawai; Rieko Okada; Asahi Hishida; Nobuyuki Hamajima; Kenji Wakai
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.